Our Company
Presentation
Management Team
Board of directors
Scientific Advisory Board
Contact
Products
Tedopi®
OSE-279
Lusvertikimab (OSE-127)
Pegrizeprument (FR104)
BI 770371
ABBV-230
CLEC-1
Research & Development
Scientific publications
Investors
Press Releases
Financial documents
General Shareholders’ meetings
Letter to Shareholders – Regulated information
Partnerships
Pharma partnerships
Clinical partnerships
Academic and public Partnerships
News
Agenda
Press Releases
Contact
en
fr
Back to agenda
Date
31/01/2024
Place
Harvard Medical School, Boston, Massachusetts
Symposium on Resolution of Inflammation in Medicine and Surgery, Harvard Medical School
January 31st, February 1st & 2nd, 2024 - Harvard Medical School, Boston (MA)